IDO2 Index™

The IDO2 Index™ drives a focused patient assessment and guides interventions to improve oxygen delivery to the patient. The Index provides a continuous risk estimation of inadequate oxygen delivery and detection of subtle changes in a patient’s condition.

  • Provides continuous estimation of a patient’s risk of experiencing a condition of inadequate oxygenation
  • Supports assessment of patient condition, trajectory of condition, and response to treatment
  • Enhances identification of patients at risk of complications related to hypoxic conditions

The IDO2 Index™ is derived using key vital signs and laboratory results collected by the T3 Software.

The IDO2 Index™ and relevant hemodynamic parameters are trended and displayed together.

T3 - Hemodynamic Patient Display

Features

 

    • IDO2 Index™ trended and updated every 5 seconds

 

    • Pre-set Hemodynamic display

 

    • Customizable display allows drag and drop of additional parameters

 

    • Trended intermittent data such as lab values
Etiometry’s IDO2 Index™ is solely indicated for use for patients under 12 years with weights above 2 kg in the United States. In Canada, the IDO2 Index is approved for use for patients under 12 years with weights above 2 kg and patients 17 years and older.
The Etiometry Platform is not an active patient monitoring system. It is intended to supplement and not replace any part of the hospital’s device monitoring. Do not rely on the Etiometry Platform as the sole source of patient status information. For prescription use only.